Takeda working with new NY nonprofit

Memorial Sloan Kettering, Rockefeller University and Weill Cornell Medical College formed the Tri-Institutional Therapeutics Discovery Institute Inc. (Tri-I TDI) to expedite early-stage discovery into clinical treatments and therapies. The institute partnered with Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) to develop small molecules. Tri-I TDI was founded with a $15 million gift from Lewis and Ali Sanders and a $5 million gift from Howard and Abby Milstein, and is funded through philanthropy and direct contributions from the three academic institutions, along with a yearly $1.5 million contribution from Takeda. Tri-I TDI will have its own scientific advisory board and board of directors. ...